Biotechnology Stocks II: Dollar-cost Averaging for Cartesian Therapeutics, Inc. (RNAC)
Dollar-cost averaging calculator assumes a $1,000 initial investment and a recurring $100 monthly investment.
All values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Dollar-cost Average Calculator Monthly Investments 2016/07/29 - 2025/04/24 | |
---|---|
Stock | RNAC |
Initial Price | $329.7150 |
Initial Investment | $1,000.00 |
Recurring Monthly Investment | $100.00 |
Initial # Shares Bought | 3.0329 |
DCA # Monthly Investments | 105 |
DCA Total Monthly Investments | $10,500.00 |
DCA # Monthly Shares Bought | 205.947 |
DCA Total Investments | $11,500.00 |
DCA Total # Shares | 208.979 |
Final Price | $12.0500 |
DCA Final Value of Total # Shares | $2,518.20 |
DCA Percent Return | -78.10% |
No DCA Total # Shares Bought | 3.0329 |
No DCA Final Value | $36.55 |
DCA Final Value - No DCA Final Value ($) | $2,481.66 |
DCA Final Value - No DCA Final Value (%) | 6,790.37% |
Stock Return Calculator |
Not enough prices to do computations. RNAC Performance Table and Chart
RNAC Compare Returns with S&P 500
RNAC Trendline Chart
RNAC Moving Average Chart
RNAC Stock Return Map - See Patterns of Gains and Losses
RNAC Stock Returns/Purchase Dates